Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;2(4):277-80.
doi: 10.4103/0976-500X.85957.

A study of adverse drug reactions in pediatric patients

Affiliations

A study of adverse drug reactions in pediatric patients

R Priyadharsini et al. J Pharmacol Pharmacother. 2011 Oct.

Abstract

Aim: To study the adverse drug reaction (ADR) pattern in a pediatric population in a tertiary care hospital.

Materials and methods: An observational study was done in the department of pediatrics in a tertiary care hospital. The ADRs occurring in the inpatient wards and outpatient department of pediatrics were actively monitored. The collected reports were analyzed for ADR pattern, drug groups, demographic profile, causality, severity, and preventability of the ADR.

Results: A total of 30 ADRs were documented during the mid period of 2009 among pediatric patients. Most of the ADRs (60%) occurred below the age of 1 year. Antibiotics comprised the major group of drugs causing ADRs (67%). Rashes and urticaria were the most common type of ADR (37%) followed by fever, anaphylactic shock, vomiting, chills, and rigors. A single case of death had been reported in the study period. There were more occurrences of ADRs with multiple drugs compared to single drug therapy. About 80% of the ADRs were of probable causality and 87% were of probable preventability. There were no mild reactions, with 77% of reactions being moderate and 23% of reactions being severe in the severity scale.

Conclusions: ADRs occur more among infants and antibiotics were more commonly implicated. Most of the reactions were of moderate severity. This indicates the need for a rigid ADR monitoring among pediatric patients to ensure safety of drug therapy.

Keywords: Adverse drug reaction; causality; pediatric; pharmacovigilance.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Causality, severity and preventability assessment of adverse drug reactions
Figure 2
Figure 2
ADR pattern in a pediatric population

References

    1. Chien JY, Ho RJ. Drug delivery trends in clinical trials and translational medicine: Evaluation of pharmacokinetic properties in special populations. J Pharm Sci. 2011;100:53–8. - PMC - PubMed
    1. Aagaard L, Hansen EH. Adverse drug reactions reported for systemic antibacterials in Danish children over a decade. Br J Clin Pharmacol. 2010;70:765–8. - PMC - PubMed
    1. Le J, Nguyen T, Law AV, Hodding J. Adverse drug reactions among children over a 10-year period. Pediatrics. 2006;118:555–62. - PubMed
    1. Bavdekar SB, Karande S. National pharmacovigilance program. Indian Pediatr. 2006;43:27–32. - PubMed
    1. Clavenna A, Bonati M. Adverse drug reactions in childhood: A review of prospective studies and safety alerts. Arch Dis Child. 2009;94:724–8. - PubMed

LinkOut - more resources